About Apnar Pharma
Apnar Pharma is a company based in Chino (United States) founded in 2014. It operates as a B2B. The company has 95 employees as of March 31, 2024. Apnar Pharma has completed 1 acquisition, including Aurex Laboratories. Apnar Pharma operates in a competitive market with competitors including Jubilant Life Sciences, Recipharm, Akums, Unither and Nectar Lifesciences, among others.
- Headquarter Chino, United States
- Employees 95 as on 31 Mar, 2024
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name Apnar Pharma Private Limited
- Date of Incorporation 12 Dec, 2014
- Jurisdiction Padra, Gujarat, India
-
Annual Revenue
$3.22 M (USD)83.73as on Mar 31, 2024
-
Net Profit
$7.51 K (USD)-88.94as on Mar 31, 2024
-
EBITDA
$783.49 K (USD)81.75as on Mar 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
95
as on Mar 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Apnar Pharma
Investments & Acquisitions by Apnar Pharma
Apnar Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Aurex Laboratories.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Drug manufacturing for multiple therapeutic areas is conducted through R&D.
|
2014 |
Financial Statements - Apnar Pharma
Apnar Pharma Comparisons
Competitors of Apnar Pharma
Apnar Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jubilant Life Sciences, Recipharm, Akums, Unither and Nectar Lifesciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| domain | founded_year | HQ Location |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| domain | founded_year | HQ Location |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| domain | founded_year | HQ Location |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| domain | founded_year | HQ Location |
Cephalosporin APIs and generic formulations are manufactured.
|
|
| domain | founded_year | HQ Location |
CDMO with a focus on early phase drug product development
|
Latest news on Apnar Pharma
Frequently Asked Questions about Apnar Pharma
Apnar Pharma was founded in 2014.
Apnar Pharma is headquartered in Chino, United States. It is registered at Chino, California, United States.
As of Mar 31, 2024, the latest employee count at Apnar Pharma is 95.
Annual revenue of Apnar Pharma is $3.22M as on Mar 31, 2024.
Apnar Pharma operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and drug production. Produces high-quality pharmaceutical products including tablets, capsules, syrups, and injectables. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Apnar Pharma's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Apnar Pharma has made 1 acquisition, including Aurex Laboratories.